Insider · CIK 0001575644
Chrysa Mineo
director
Files at CDTX (Cidara Therapeutics, Inc.). First filing Jun 4, 2025, latest Jun 4, 2025.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 0
$74k bought, $0 sold
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 18, 2025 | CDTX Cidara Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +11,100 | $0.00 | $0 | 11,100 | Jun 18, 2025 |
| Jun 2, 2025 | CDTX Cidara Therapeutics, Inc. | POpen-market purchase Common Stock | +2,270 | $21.71 | $49k | 2,270 | Jun 4, 2025 |
| Jun 3, 2025 | CDTX Cidara Therapeutics, Inc. | POpen-market purchase Common Stock | +1,050 | $23.44 | $25k | 3,320 | Jun 4, 2025 |
| Dec 17, 2024 | CDTX Cidara Therapeutics, Inc. | AGrant or award Stock Option (right to buy)derivative | +19,000 | $0.00 | $0 | 19,000 | Dec 19, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.